Skip to content

Curcumin organogel for osteoarthritis treatment

The effect of a Curcumin organogel on knee osteoarthritis: a randomized placebo trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220531055045N1
Enrollment
70
Registered
2022-06-11
Start date
2022-06-06
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: Applying Curcumin OG 2% twice a day for 8 weeks on the knee area. Intervention 2: Control group: Applying Curcumin-free OG, twice a day, up to 8 weeks, on the knee

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: Having symptom of pain in joint Osteoarthritis (at Knee), stiffness, difficulty in flexion and extension, swelling for more than 3 months prior to the study Being free of any systemic or dermatological diseases Willing to refrain from using any lotion, gel, balm, moisturizer, cleanser, cosmetic or cream on the treatment areas during the treatment period Being able to give written informed consent in a manner approved by the Institutional Ethics Committee and complying with the requirements of the study Willing to avoid participation in any other interventional clinical trial during current study No known allergy to Curcumin and plants of the ginger family

Exclusion criteria

Exclusion criteria: Showing a systemic or local allergic reaction to Curcumin organogel Discontinuation of the treatment before end of intervention, or stopping it for at least three consecutive days A decision to withdraw from the study Death Hospitalization Moving to another city

Design outcomes

Primary

MeasureTime frame
Pain, Stiffness, Difficulty in knee movement. Timepoint: Before, 1, 2, 4 and 8 weeks after intervention. Method of measurement: The Western Ontario and McMaster Universities Arthritis Index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholamhossein Yousefi

Shiraz University of Medical Sciences

ghyousefi@sums.ac.ir+98 71 3242 4127

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026